A 2.5 mg track has short direct data and real-world support for stable maintainers, but continuing tirzepatide has much stronger evidence than stopping. At week 112, stepping down to 5 mg preserved 16.6% weight loss versus 21.9% on the top dose and 9.9% on placebo
Shi et al., 2011), and decreased in DLBD in comparison with PD, PDD (Hall et al., 2012
Thyroid tumor symptoms : Patients should report symptoms such as neck mass, dysphagia, hoarseness, or dyspnea
Research suggests that people who maintain weight loss over time often share several behaviours: Keeping energy intake moderate and increasing calories gradually if needed Eating regularly, at similar times each day, including weekends Eating breakfast daily, with a balanced meal that supports steadier eating later in the day Choosing nutrient dense foods such as vegetables, pulses, wholegrains, fish, eggs and chicken, and limiting foods high in energy but low in nutrients, such as sweets, pastries and alcohol Weighing themselves regularly, for example once a week, even after reaching target weight Keeping a food diary at times to stay aware of intake Staying physically active every day
Yes Durham Peptides stocks CagriSema , tirzepatide , and retatrutide